Abstract:Objective To explore the value of next-generation sequencing for the non-invasive prenatal testing of fetal chromosomal aneuploidies.Methods Plasma from 4004 women with singleton pregnancy at a gestational age between 12～35+5 weeks was collected prior to amniocentesis between April 19th 2011 and December 31st 2013.The samples were divided into three groups:(1) High risk for Down syndrome by biochemical screening;(2) Advanced maternal age;(3) Abnormalities by ultrasound or other methods.Plasma DNA extracted from above samples was sequenced at low coverage.Positive results were verified against the karyotypes of the fetuses.For those with negative results,the fetuses were followed up by telephone call for at least six months after birth.Results Among 4003 samples subjected to non-invasive prenatal diagnosis,66 (1.65％) had a positive result.In group 1,22 cases of trisomy 21 (T21),3 cases of risomy 18 (T18),1 case of 13 trisomy (T13),8 cases of 45,X and 2 cases of other chromosomal abnormality were detected.In group 2,13 cases of T21,2 cases of T18,1 case of T13,5 cases of 45,X,2 cases of 47,XXN and 1 case of other chromosomal abnormality were detected.In group 3,1 case of T21,1 case of T18,1 case of T13,and 3 cases of 47,XXN were detected.For 55 samples underwent prenatal diagnosis,30 cases of T21 and 4 cases of T18 were discovered,which was consistent with the results of noninvasive prenatal diagnosis.For the 13 cases indicated as 45,X,3 were verified by karyotype analysis,2 were verified as mosaicism (45,X/46,XN),8 were 46,XN (false positives).For the 5 cases indicated as 47,XXN,2 were verified by karyotype analysis,the other 3 were 46,XN (false positives).Karyotypes of 3 cases suspected for other chromosomal abnormalities were all verified as 46,XN (false positive).Until May 1st 2014,telephone follow-up for those with negative screening results only identified a boy with facial abnormalities and developmental delay,which was similar to his older sister,combined karyotyping and fluorescence in situ hybridization analysis has verified the karyotype of the boy as 46,XY,rec(14)dup(14q) inv(14)(p12q14)pat.Conclusion Our results indicated that sequencing of plasma free DNA can rapidly detect fetal chromosomal aneuploidies.The method is non-invasive,and the results are highly consistent with karyotype analysis in terms of accuracy and specificity.Non-invasive testing can be used as an effective adjunct to conventional prenatal diagnostic methods,which can greatly reduce unnecessary invasive prenatal diagnosis.However,the sensitivity and accuracy for aneuploidy detection other than chromosome 13/18/21 still need to be improved.

[Non-Invasive Prenatal Diagnosis of Fetal Down Syndrome by Dual-Color Fluorescence in Situ Hybridization with Co-Denaturation].

[The Application of Dual-Color Fluorescence in Situ Hybridization to the Diagnosis of Klinefelter Syndrome].

[Rapid Detection of Chromosomes X and Y Using Dual-Color Primed in Situ Labeling Technique].

Noninvasive Prenatal Screening of Fetal Aneuploidy without Massively Parallel Sequencing

Noninvasive prenatal screening of Down's syndrome by fetal nucleated erythrocytes detection in maternal blood combined with serum screening and three-dimensional ultrasound

Prenatal Diagnosis of Down Syndrome Using Cell-Free Fetal DNA in Amniotic Fluid by Quantitative Fluorescent Polymersase Chain Reaction.

Prenatal Diagnosis of Common Chromosomal Aneuploidies on Uncultured Amniotic Fluid Cells by Fluorescence in Situ Hybridization

Noninvasive Prenatal Detection of Down Syndrome: Are We Finally Getting the Right Message?

Prenatal Diagnosis of Common Chromosomal Aneuploidies by Fluorescence in Situ Hybridization

[Application of Real-Time Fluorescence Quantitative Polymerase Chain Reaction Techniques for Prenatal Diagnosis of Down Syndrome].

Prenatal diagnosis for chromosome aneuploidies in 50 amniotic fluid samples with fluorescence in situ hybridization

Molecular Cytogenetic Detection of Trisomy 21 in Interphase Nuclei and Metaphase Chromosomes.

Rapid Prenatal Diagnosis of Down Syndrome by Quantitative Fluorescence Polymerase Chain Reaction

Systematic Review of Noninvasive Prenatal Diagnosis for Abnormal Chromosome Genetic Diseases Using Free Fetal DNA in Maternal Plasma

The Application of NIPT Using Combinatorial Probe-Anchor Synthesis to Identify Sex Chromosomal Aneuploidies (scas) in a Cohort of 570 Pregnancies

Noninvasive prenatal diagnosis of trisomy 21 using analysis of short tandem repeats

Detection of fetal duplication 16p11.2q12.1 by next-generation sequencing of maternal plasma and invasive diagnosis.

Novel Real-Time Pcr Assay for Rapid Prenatal Diagnosis of Down Syndrome: A Prospective Study of 563 Amniocytes

Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing.

An Optimized Method for Accurate Fetal Sex Prediction and Sex Chromosome Aneuploidy Detection in Non-Invasive Prenatal Testing.

Application of next-generation DNA sequencing for prenatal testing of fetal chromosomal aneuploidies